We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products.

Becton, Dickinson and Company's prefilled syringes and self-administered injection systems could be used for GLP-1 market.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Medical device company Becton Dickinson (BD) may be nearing the end of a shortage of plastic bottles used to contain ...

Shares of Becton Dickinson & Co. BDX sank 0.06% to $234.04 Monday, on what proved to be an all-around positive trading ...

Becton, Dickinson (NYSE:BDX), or BD, on Thursday said it had agreed to pay $85M to settle claims that it had failed to ...

Becton Dickinson & Co. agreed to acquire an Edwards Lifesciences unit for $4.2 billion, in one of the company’s largest of ...

On the evening of April 23, Becton Dickinson announced it had reached a deal to acquire Bard for $24bn in cash and shares – the latest in a series of major deals in the medical technology sector. A ...

Zacks Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off Embecta is exploring a potential sale after a nearly 70% drop in share price since its ...

Becton Dickinson & Co. closed $33.83 short of its 52-week high ($269.52), which the company reached on October 10th.